Your browser doesn't support javascript.
loading
Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia.
Giraldo, Diana L; Sijbers, Jan; Romero, Eduardo.
Afiliação
  • Giraldo DL; Computer Imaging and Medical Applications Laboratory - CIM@LAB Universidad Nacional de Colombia Bogotá Colombia.
  • Sijbers J; imec-Visionlab Department of Physics at University of Antwerp University of Antwerp Antwerp Belgium.
  • Romero E; imec-Visionlab Department of Physics at University of Antwerp University of Antwerp Antwerp Belgium.
Alzheimers Dement (Amst) ; 13(1): e12237, 2021.
Article em En | MEDLINE | ID: mdl-34541290
ABSTRACT

INTRODUCTION:

Neuropsychological test scores are limited and standard outcomes may mask the heterogeneity of cognitive impairment. This article presents the calculation and evaluation of six composite scores that quantify domain-specific impairment.

METHODS:

Parameters for composite scores calculation were learned by performing confirmatory factor analysis in a sample of participants from the Alzheimer's Disease Neuroimaging Initiative database. The obtained scores were evaluated with a separate sample of mild cognitive impairment (MCI) in two automated tasks unsupervised partition in different subgroups and prediction of progression to dementia for different time windows.

RESULTS:

MCI subgroups with distinctive cognitive profiles and risk of progression emerged from cluster analysis. Composite scores outperform standard neuropsychological tests when automatically predicting progression within time windows up to 5 years.

CONCLUSIONS:

Domain-specific composite scores are useful to delineate profiles of impairment, stratify the MCI risk, and predict progression to dementia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article